The Food and Drug Administration (FDA) has issued a recall affecting over 3 million containers of eye drops sold across the United States, including locations in the San Antonio area. The recall, designated as a Class II action by the FDA on March 31, indicates that there can be temporary or medically reversible adverse health consequences associated with the affected products, although the likelihood of serious health issues is considered remote.
The primary reason for the recall is a “lack of assurance of sterility,” which raises concerns about the potential for contamination in the eye drop solution. K.C. Pharmaceuticals, Inc., based in California, is the manufacturer of the eye drops, which have been distributed under various brand names to numerous retail outlets, including H-E-B, Walgreens, Walmart, and CVS.
Customers are urged to check their medicine cabinets for the affected H-E-B branded products, as there is a risk that they may be using contaminated eye drops. A comprehensive list of the specific product names, expiration dates, and the stores implicated can be accessed through the official FDA report.
In light of this recall, consumers are advised to stop using the affected eye drops immediately and return them to the place of purchase for a full refund or dispose of them properly to avoid potential health risks. As the situation develops, the FDA continues to monitor the recall to ensure consumer safety and provide updates where necessary.
